Assyro AI

Orange Book product · Brand (NDA)

VANTRELA ER

HYDROCODONE BITARTRATE

Brand (NDA)NDA 207975DISCN TEVA BRANDED PHARM

At a glance

Jan 17, 2017

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 17, 2017

    9 yr 7 mo ago

  2. Today

  3. Patent 9216176 expires

    Listed drug product patent expiration.

    Sep 13, 2027

    in 1 yr 3 mo

  4. Patent 9572803 expires

    Listed drug product patent expiration.

    Sep 13, 2027

    in 1 yr 3 mo

  5. Patent 8445018 expires

    Listed drug product patent expiration.

    Jul 31, 2029

    in 3 yr 2 mo

Pharmaceutical detail

Active ingredient

HYDROCODONE BITARTRATE

Strength

15MG

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

TE code

Not listed

Application

NDA 207975

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9216176Sep 13, 2027in 1 yr 3 mo
Product
9572803Sep 13, 2027in 1 yr 3 mo
Product
8445018Jul 31, 2029in 3 yr 2 mo
Product
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.